News
Every year, thousands of new materials are created, yet many never reach their full potential because their applications aren't immediately obvious—a challenge University of Toronto researchers aim to ...
Lentiviral Vector CDMO Market sees 8% CAGR as gene therapy pipeline and R&D investments grow by 2030
The global lentiviral vector CDMO market is set to witness a growth rate of 8% in the next 5 years. Growing demand for gene ...
Current approaches in bioengineering are synthesized and methods for their implementation are suggested for the induction and modulation of trained immunity in the treatment of human diseases.
An OpenAI exec says the company is embedding engineers with clients to speed up AI adoption and move projects from trial to ...
S3 Vectors allows customers to store AI vector data in S3 object storage, a move that potentially allows for much cheaper storage of vectorised data usually held in vector databases.
Hanut Singh, a robotics application engineer, said roles like his are the future of the tech industry.
Platform engineering is about making developers’ lives easier. Automating the steps needed to create and maintain infrastructure keeps your developers focused on building software, not keeping the ...
AgentCore-powered agents and other AI applications can keep their data in Amazon S3 Vectors, a new storage offering that also ...
Chinese scientists have developed a novel AI-guided protein engineering strategy that enables faster, cost-effective, and highly accurate protein design. A group of scientists in China, led by Profess ...
14d
ITWeb on MSNTop cyber attack vectors organisations faceTop cyber attack vectors organisations faceIt’s important to look at the attack vectors threat actors are utilising to understand how organisations can harden their defences.Issued by Arctic Wolf ...
With its proprietary platform Invir.IO®, Transgene is building on its viral vector engineering expertise to design a new generation of multifunctional oncolytic viruses.
Strasbourg, France, July 9, 2025, 5:45 p.m. CET - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results